Thursday, November 8, 2012 Tuesday, November 6, 2012 Monday, November 5, 2012 Sunday, November 4, 2012 Friday, November 2, 2012- Vertex's Shocking Decline Hurts Investorsat Motley Fool (Fri, Nov 2)
- Vertex Reaches Deal With GSK, Mistaken Headline On Questcor: Healthcare Business Recapat Wall St. Cheat Sheet (Fri, Nov 2)
- Can Vertex Overcome Plunging Sales?at Wall St. Cheat Sheet (Fri, Nov 2)
- For Hep C Investors, What Goes Around Comes Aroundat Motley Fool (Fri, Nov 2)
- Stocks Start Firm But End Sloppy As Volume Fadesat Investor's Business Daily (Fri, Nov 2)
- Vertex sinks as Incivek sales decline furtherAP (Fri, Nov 2)
- This Just In: More Upgrades and Downgradesat Motley Fool (Fri, Nov 2)
- Vertex Stock Falls On Unusually High Volume (VRTX)at TheStreet (Fri, Nov 2)
- Vertex shares tank on swing to redat bizjournals.com (Fri, Nov 2)
- Advance Auto Analyst Sees $90 Takeout and 4 Stock Analyses Sparking Chatterat Wall St. Cheat Sheet (Fri, Nov 2)
- Vertex Pharmaceuticals Shares Drop on Disappointing Sales, Quarterly Lossat Minyanville (Fri, Nov 2)
- Starbucks Among the Nasdaq's Biggest Movers on November 2, 2012at Investopedia (Fri, Nov 2)
- Vertex Pharmaceuticals and Other Healthcare Stocks Making Big Moves on November 2, 2012at Investopedia (Fri, Nov 2)
- Stocks Open Up And Down; Vertex Pharmaceuticals Tanksat Investor's Business Daily (Fri, Nov 2)
- Analysts' Actions: ABX EGO VRTX FSLR LNKDTheStreet (Fri, Nov 2)
- Vertex should be bought on weakness, says Brean Capital at Brean Capitaltheflyonthewall.com (Fri, Nov 2)
Thursday, November 1, 2012Add VRTX News to My Yahoo!  | |
|